Comparison between Veeda Clinical Research IPO and Vinir Engineering IPO.
Veeda Clinical Research IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Vinir Engineering IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Veeda Clinical Research IPO is up to ₹0.00 Cr whereas the issue size of the Vinir Engineering IPO is up to ₹0.00 Cr. The final issue price of Veeda Clinical Research IPO is and of Vinir Engineering IPO is .
| Veeda Clinical Research IPO | Vinir Engineering IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹2 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹185.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 1,30,08,128 shares | 5,33,00,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 5,33,00,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Veeda Clinical Research IPO opens on , while Vinir Engineering IPO opens on . The closing date of Veeda Clinical Research IPO and Vinir Engineering IPO is , and , respectively.
Veeda Clinical Research IPO P/E ratio is , as compared to Vinir Engineering IPO P/E ratio of .
| Veeda Clinical Research IPO | Vinir Engineering IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 33.83 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 26.68% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 35.21% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.32 | 0.13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -0.02% | 26.68% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Veeda Clinical Research IPO Retail Individual Investors (RII) are offered while in Vinir Engineering IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Veeda Clinical Research IPO and in Vinir Engineering IPO.
Veeda Clinical Research IPO subscribed in total, whereas Vinir Engineering IPO subscribed .
| Veeda Clinical Research IPO | Vinir Engineering IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
